KR102486047B1 - 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 - Google Patents
근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 Download PDFInfo
- Publication number
- KR102486047B1 KR102486047B1 KR1020200174844A KR20200174844A KR102486047B1 KR 102486047 B1 KR102486047 B1 KR 102486047B1 KR 1020200174844 A KR1020200174844 A KR 1020200174844A KR 20200174844 A KR20200174844 A KR 20200174844A KR 102486047 B1 KR102486047 B1 KR 102486047B1
- Authority
- KR
- South Korea
- Prior art keywords
- muscle
- gly
- ser
- leu
- ala
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200174844A KR102486047B1 (ko) | 2020-12-14 | 2020-12-14 | 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 |
PCT/KR2021/018973 WO2022131750A1 (fr) | 2020-12-14 | 2021-12-14 | Composition pour le traitement ou la prévention de la myopathie, de l'obésité ou du diabète |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200174844A KR102486047B1 (ko) | 2020-12-14 | 2020-12-14 | 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220084898A KR20220084898A (ko) | 2022-06-21 |
KR102486047B1 true KR102486047B1 (ko) | 2023-01-11 |
Family
ID=82059316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200174844A KR102486047B1 (ko) | 2020-12-14 | 2020-12-14 | 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102486047B1 (fr) |
WO (1) | WO2022131750A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180140684A1 (en) | 2012-11-15 | 2018-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of muscle and adipocyte distribution and fate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055643A1 (fr) * | 1997-06-03 | 1998-12-10 | Kureha Chemical Industry Co., Ltd. | Proteine adamts-1 humaine, gene codant pour cette proteine, composition pharmaceutique et procede de dosage immunologique de proteine adamts-1 humaine |
EP1136547A3 (fr) * | 2000-03-22 | 2002-09-25 | Pfizer Products Inc. | Polypeptides Adamts, acides nucléiques codant pour ces polypeptides et leurs utilisations |
WO2007147497A2 (fr) * | 2006-06-17 | 2007-12-27 | Bayer Healthcare Ag | Utilisation d'un domaine du type désintégrine et métalloprotéinase à motif de thrombospondine de type 1 (adamts1) comme cible thérapeutique et diagnostique |
-
2020
- 2020-12-14 KR KR1020200174844A patent/KR102486047B1/ko active IP Right Grant
-
2021
- 2021-12-14 WO PCT/KR2021/018973 patent/WO2022131750A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180140684A1 (en) | 2012-11-15 | 2018-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of muscle and adipocyte distribution and fate |
Non-Patent Citations (1)
Title |
---|
Pharmacogenetics and genomics, 2010, Vol.20, pp.766-774 |
Also Published As
Publication number | Publication date |
---|---|
WO2022131750A1 (fr) | 2022-06-23 |
KR20220084898A (ko) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4487376B2 (ja) | 腎疾患治療剤 | |
US11040072B2 (en) | Composition for inducing beige adipocyte differentiation containing exosome derived from stem cells | |
KR101966117B1 (ko) | 가공인삼추출물을 포함하는 근육 분화 촉진용 조성물 | |
CA2229479C (fr) | Procede de stimulation de l'angiogenese | |
EP2937088B1 (fr) | Composition présentant une activité de réparation tissulaire et son utilisation | |
KR20070109004A (ko) | 오미자 추출물을 포함하는 골대사질환, 산화적 스트레스에의한 질환, 염증성질환의 예방과 치료용 약학조성물 | |
WO2013044511A1 (fr) | Composition pharmaceutique contenant du riligustilide et utilisation associée | |
JP2004529916A (ja) | パーキンソン病の治療において神経栄養活性化合物と組み合わせたアデノシンa2aレセプターアンタゴニスト | |
KR102174191B1 (ko) | 조직 재생 및 저하된 조직 기능의 회복을 자극하기 위한 제제로서의 디카르복시산의 비스아미드 유도체 | |
KR102486047B1 (ko) | 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 | |
KR102486046B1 (ko) | 근육질환, 비만 또는 당뇨병 치료, 또는 예방용 조성물 | |
US20080300182A1 (en) | Eye disease treating agent and method for treating eye disease | |
KR102042084B1 (ko) | 에스트라디올 전처리에 의해 생존율이 향상된 줄기세포와 그 제조방법, 및 이를 포함하는 당뇨병 및 이와 관련된 질병의 예방 또는 치료를 위한 세포치료제 조성물 | |
KR20150071932A (ko) | Taz 단백질 활성화 유도 성분을 포함하는 근육 분화 및 근육재생용 약학적 조성물 | |
KR102076777B1 (ko) | Gas6 단백질 또는 이의 수용체 활성화제를 포함하는 섬유증의 예방 또는 치료용 조성물 | |
EP4378468A1 (fr) | Composition pour le traitement de maladies liées à la perte musculaire comprenant des exosomes dérivés de cellules souches mésenchymateuses de l'amygdale | |
TWI818286B (zh) | 包括表現腫瘤壞死因子可誘導基因6的間葉幹細胞之組成物及藥物組成物 | |
KR20210116350A (ko) | 심장줄기세포를 포함하는 허혈성 질환의 예방 또는 치료용 조성물 | |
KR20210020818A (ko) | 초과 추출물을 함유하는 근육 감소 관련 질병의 예방, 개선, 또는 치료용 조성물 | |
KR20110105439A (ko) | 항비만 또는 체지방감소를 위한 조성물 | |
CN117442603B (zh) | 夏佛塔苷在制备抗心力衰竭药物中的应用 | |
WO2024122720A1 (fr) | Peptide pour régénérer le cartilage et ses utilisations | |
Andersson et al. | Release of endothelin-1 into rat airways following Sephadex-induced inflammation; modulation by enzyme inhibitors and budesonide | |
WO2024122721A1 (fr) | Peptide pour régénérer le cartilage et ses utilisations | |
WO2024122726A1 (fr) | Peptide pour la régénération du cartilage et ses utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |